The European Medicines Agency’s goals for regulatory science to 2025

Philip Hines, Richard Guy, Anthony Humphreys, Marisa Papaluca-Amati

Research output: Contribution to journalComment/debatepeer-review

13 Citations (SciVal)
40 Downloads (Pure)


It is increasingly important that regulatory agencies catalyse the translation of scientific and technological innovation into improved patient-centred health care. Here, we highlight the strategic goals of the European Medicines Agency to advance regulatory science and optimize the opportunities arising in areas such as cell and gene therapies, big data and artificial intelligence.

Original languageEnglish
Pages (from-to)403-404
Number of pages2
JournalNature Reviews Drug Discovery
Issue number6
Early online date15 Apr 2019
Publication statusPublished - 3 Jun 2019


  • Drug discovery

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'The European Medicines Agency’s goals for regulatory science to 2025'. Together they form a unique fingerprint.

Cite this